Selected article for: "mutation rate and RNA virus"

Author: Mehta, Chitra; Kataria, Sushila; Mehta, Yatin
Title: Management of Coronavirus 2019
  • Cord-id: eevqclsy
  • Document date: 2020_4_24
  • ID: eevqclsy
    Snippet: Coronavirus 2019 (COVID-19) disease is the most recent global public health problem. It is caused by SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2), which is a RNA virus with a high mutation rate, belonging to the genus Coronavirus . The objective of this communication is to provide an initial understanding regarding pathophysiology, clinical manifestations, management, and prevention of this devastating disease.
    Document: Coronavirus 2019 (COVID-19) disease is the most recent global public health problem. It is caused by SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2), which is a RNA virus with a high mutation rate, belonging to the genus Coronavirus . The objective of this communication is to provide an initial understanding regarding pathophysiology, clinical manifestations, management, and prevention of this devastating disease.

    Search related documents:
    Co phrase search for related documents
    • ace inhibitor and acute cardiac injury: 1, 2
    • ace inhibitor and acute coronary syndrome: 1
    • ace inhibitor and acute kidney injury: 1, 2, 3, 4
    • ace inhibitor and acute lung injury: 1, 2, 3, 4
    • ace inhibitor and acute respiratory failure: 1
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor and adaptive immunity: 1
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute ards respiratory distress syndrome and adaptive immunity: 1, 2, 3, 4, 5, 6, 7
    • acute coronary syndrome and adaptive immunity: 1
    • acute kidney injury and adaptive immune response: 1, 2
    • acute kidney injury and adaptive immunity: 1, 2, 3
    • acute kidney injury and additional azithromycin: 1
    • acute lung injury and adaptive immune response: 1, 2, 3, 4, 5
    • acute lung injury and adaptive immunity: 1, 2, 3, 4, 5, 6
    • acute respiratory failure and adaptive immune response: 1, 2, 3, 4
    • acute respiratory failure and adaptive immunity: 1, 2, 3, 4, 5
    • acute respiratory failure and additional azithromycin: 1
    • acute respiratory syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25